Skip to content

Clinical trials

Observational Blood Platelet Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Platelet Disorders Phase: Observational Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20131
20141
20192
20201
20213
20221
20232
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed5
Recruiting3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM1
American Thrombosis and Hemostasis Network1
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari1
Boston Children's Hospital1
Centre Hospitalier Universitaire, Amiens1
Clinical Hospital Centre Zagreb1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Platelet Disorders18
Hemorrhage4
Hematologic Diseases3
Hemostatic Disorders3
Blood Coagulation Disorders2
Hemorrhagic Disorders2
Immune System Diseases2
Kidney Diseases2
Purpura, Thrombocytopenic, Idiopathic2
Thrombocytopenia2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.